⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
ASAP3–Actin–Autophagy Hepatic Senescence Axis
Current understanding
ASAP3, an ArfGAP-family regulator of actin cytoskeleton dynamics, is nominated as a driver of hepatic aging: mouse Asap3 knockouts show alleviated hepatocyte senescence, restored actin dynamics, enhanced autophagy, and improved mitochondrial function, alongside extended lifespan and healthspan [animal-model]. The proposed mechanism couples cytoskeletal disorganization to autophagic flux and mitochondrial quality control in the liver, but all evidence is preclinical (mouse KO + cell work) with no human translation.
Evidence log
- 2026-09-15 — Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK.: cross-connection with hepassocin-ampk-liver-aging: Both nominate liver-intrinsic upstream nodes gating hepatocyte senescence and healthspan — ASAP3 via actin–autophagy–mitochondria, hepassocin via secreted-factor engagement of LKB1–AMPK. (novelty: 3)
Open questions
Related
Contributing findings
ASAP3 deficiency alleviates hepatic senescence and correlates with extended healthspan in mice.
10-jul-2026
novelty 3
per-area 3
introduces